Nomegestrol acetate in contraception and venous thrombotic risk
Jamin, C.
Gynecologie Obstetrique and Fertilite 40(7-8): 394-395
2012
ISSN/ISBN: 1769-6682 PMID: 22749671 DOI: 10.1016/j.gyobfe.2012.03.007Document Number: 552704
Document emailed within 0-6 h
Related Documents
Burke, A. 2013: Nomegestrol acetate-17b-estradiol for oral contraception Patient Preference and Adherence 7: 607-619Jamin, C. 1992: Female contraception by a normal dose progestogen after 40 years of age. Possible association of nomegestrol--17-beta-estradiol acetate by percutaneous route Revue Francaise de Gynecologie et D'obstetrique 87(6): 370-376
Grandi, G.; Napolitano, A.; Xholli, A.; Tirelli, A.; Di Carlo, C.; Cagnacci, A. 2015: Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 31(10): 774-778
Appertflory, A.; Fischer, F.; Toulon, P. 2005: Contraception orale estroprogestative et thrombophilie : Contraception : mise au point sur les nouveautés et les difficultés - Oral contraceptives and risk of venous thrombosis la Lettre du Gynecologue (300): 36-39
K.-G. Heinze 2000: Molecular Risk Factors for Thrombosis and Risk Factors in Venous Thrombotic Disease Clinical Laboratory 46(3-4): 197-194
Pintiaux, A.; Gaspard, U.; Nisolle, M. 2012: Zoely, a combined oral contraceptive, monophasic pill containing estradiol and nomegestrol acetate Revue Medicale de Liege 67(3): 152-156
Basdevant, A.; Pelissier, C.; Conard, J.; Degrelle, H.; Guyene, T.T.; Thomas, J.L. 1991: Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal women Contraception 44(6): 599-605
Arowojolu, A.O.; Adekunle, O.A.; Ogunnowo, T.O.; Otolorin, E.O.; Ladipo, O.A. 2000: Vaginal bleeding patterns in Nigerian users of nomegestrol acetate subdermal contraceptive implant African Journal of Medicine and Medical Sciences 29(3-4): 275-279
André, E.; Hacquard, M.; Alnot, Y.; de Maistre, E.; Lecompte, T. 2007: Activated protein C resistance test using factor VIII-deficient plasma: a new approach to the venous thrombotic risk? Thrombosis and Haemostasis 98(3): 693-694
Pola, E.; Papaleo, P.; Cerciello, S.; Aulisa, A.G.; Mazza, O.; Aulisa, L. 2003: An effective method to prevent deep venous thrombosis in total hip arthroplasty: a study in patients with and without risk factors for thrombotic disease La Clinica Terapeutica 154(3): 151-157
Kaunitz, A.M. 1996: Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer Journal of Reproductive Medicine 41(5 Suppl): 419-427
Blanc, B.; Cravello, L.; Micheletti, M.C.; d'Ercole, C.; Zartarian, M. 1998: Continuous hormone replacement therapy for menopause combining nomegestrol acetate and gel, patch, or oral estrogen: a comparison of amenorrhea rates Clinical Therapeutics 20(5): 901-912
Ågren, U.M.; Anttila, M.; Mäenpää-Liukko, K.; Rantala, M.-L.; Rautiainen, H.; Sommer, W.F.; Mommers, E. 2011: Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 16(6): 458-467
Ruan, X.; Schneck, H.; Schultz, S.; Fehm, T.; Cahill, M.A.; Seeger, H.; Chen, R.; Yu, Q.; Mueck, A.O.; Neubauer, H. 2012: Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 28(11): 863-866
Kapur, R.; Stramrood, C.A.I.; Schutgens, R.E.G.; van Asbeck, B.Sweder. 2009: Cyproterone acetate- and ethinyloestradiol-containing oral contraceptive as a risk factor for upper extremity deep venous thrombosis-a case report European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 14(2): 160-163
Gaussem, P.; Alhenc-Gelas, M.; Thomas, J.-L.; Bachelot-Loza, C.; Remones, V.; Ali, F.D.; Aiach, M.; Scarabin, P.-Y. 2011: Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. a double-blind, randomised study Thrombosis and Haemostasis 105(3): 560-567
Han, L.; Jensen, J.T. 2015: Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk? Obstetrics and Gynecology Clinics of North America 42(4): 683-698
Le Moigne, E.; Tromeur, C.; Delluc, A.; Gouillou, M.; Alavi, Z.; Lacut, K.; Mottier, D.; Le Gal, G. 2016: Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study Haematologica 101(1): E12-E14
De Kam, P.-J.; van Kuijk, J.; Lillin, O.; Post, T.; Thomsen, T. 2014: The effect of therapeutic and supratherapeutic oral doses of nomegestrol acetate (NOMAC)/17β-estradiol (E2) on QTcF intervals in healthy women: results from a randomized, double-blind, placebo- and positive-controlled trial Clinical Drug Investigation 34(6): 413-420
Pelissier, C.; Basdevant, A.; Conard, J.; Egloff, M.; Husson, T.; Guyenne, T.T. 1987: Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study) Contraception Fertilite Sexualite 15(1): 45-54